Characterization of phase I and phase II metabolism of UR-1102, a novel agent for the treatment of gout

詳細情報 詳細情報について

• CRID

  1360571323607225600

• NII論文ID

  50014569207

• DOI

  10.1016/j.dmpk.2017.11.110

• ISSN

  13474367

• Web Site

  https://api.elsevier.com/content/article/PII:S1347436717303415?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1347436717303415?httpAccept=text/plain

  https://search.jamas.or.jp/link/ui/2021209389

• データソース種別

  • Crossref
  • CiNii Articles